DGAP-Adhoc: CANCOM: strong growth in revenues and profit

New Post Public Reply Private Reply Replies (0) Message Board

News Desk 2018

Jul 30, 2014 at 10:30 AM

DGAP-Adhoc: CANCOM: strong growth in revenues and profit continues in q2

CANCOM SE / Key word(s): Preliminary Results 30.07.2014 16:14 Dissemination of an Ad hoc announcement according to Â§ 15 WpHG, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- CANCOM: strong growth in revenues and profit continues in q2 Munich, Germany, 30 July 2014 - With publishing provisional figures for q2 and the first half of 2014 CANCOM SE continues to show strong growth in revenues and profits year-on-year. In detail, the group's consolidated sales revenues for q2 were up to EUR 189.3 million according to the provisional figures and compared to EUR 140.0 million in 2013. This is equivalent to an increase of 35.2 percent. Preliminary Group EBITDA adjusted for one-off effects for the second quarter was EUR 11.4 million, 46.2 percent higher than the figure of EUR 7.8 million in q2/2013. Respectively the adjusted EBITDA margin is 6.0 percent as compared with 5.6 percent in 2013 and shows the group's increased profitability. The one-off effects of EUR 0.1 million are external expenses in connection with the acquisitions, not to be capitalized pursuant to IFRS and not incurred related to the operational business. Preliminary Group EBITA (earnings before interest, taxes and amortization on intangible assets) adjusted for one-off effects is EUR 8.2 for q2, compared with EUR 5.8 million in 2013, a plus of 41.4 percent. For the first six months of the current financial year, the group's consolidated sales revenues grew 36.2 percent up to EUR 374.7 million according to the provisional figures compared to EUR 275.1 million in the previous year. Preliminary Group EBITDA adjusted for one-off effects amounting to EUR 0.6 million in the first half of 2014 was EUR 22.0 million and 48.6 percent higher than the figure of EUR 14.8 million recorded in the first half of 2013. The adjusted EBITDA margin was up from 5.4 percent in 2013 to 5.9 percent. Preliminary Group EBITA for the first half of 2014 amounts to EUR 15.8 million compared to EUR 10.9 million in 2013 - an increase of 45.0 percent. The full report for the second quarter will be published on 7 August 2014. Contact: Beate Rosenfeld Manager Corporate Communication & IR CANCOM SE Erika-Mann-StraÃe 69 80636 MÃ¼nchen Germany Phone: +49 (0) 89 / 54054 5193 mail to: beate.rosenfeld@cancom.de www.cancom.de 30.07.2014 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: CANCOM SE Erika-Mann-StraÃe 69 80636 MÃ¼nchen Germany Phone: +49-(0)89/54054-0 Fax: +49-(0)89/54054-5119 E-mail: info@cancom.de Internet: http://www.cancom.de ISIN: DE0005419105 WKN: 541910 Indices: TecDAX Listed: Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr in Berlin, DÃ¼sseldorf, Hamburg, MÃ¼nchen, Stuttgart End of Announcement DGAP News-Service ---------------------------------------------------------------------------

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Faith and Resilience in China: The Legacy of the Long March

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Antheia Secures $80M for Critical Medicine Onshoring

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Lundbeck's Board Leadership Transitions into New Era

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Tomorrowland's Shanghai Return: An Electri-Lifesaver

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

AEVEX Faces 48-Hour Deadline for Investor Class Action

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

ASTS Faces a Legal Countdown – Investors Take Note

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

UEG's New Advisory Board: Elevating Patient Voices

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Top 5 Most Recently Viewed Articles

CareDx and Dovetail Genomics Forge New Path in Transplant Solutions

Partnership to Enhance HLA Typing Technology CareDx, Inc. (NASDAQ: CDNA), renowned for its pioneering precision medicine approach for transplant patients, has recently joined forces with Dovetail Genomics, a recognized leader in genomic solutions. This notable collaboration is set to introduce an Early Access Program designed for HLA laboratories, leveraging a unique...

Pet Valu Holdings Secures C$150 Million Through Secondary Offering

Pet Valu Holdings Hits Milestone with Recent Secondary Offering MARKHAM, Ontario — Pet Valu Holdings Ltd. (“Pet Valu” or the “Company”) (TSX: PET), a prominent name in Canadian specialty retailing, has unveiled the successful completion of its secondary bought deal offering. This initiative has generated an impressive C$150 million through the sale of 5,200,000...

SMCP Settles Legal Proceedings Over 15.9% Stake Dispute

Overview of SMCP's Recent Legal Developments In a significant update, SMCP has received confirmation regarding the legal proceedings related to a notable 15.9% stake in its share capital. The London Court of Appeal has denied requests from Dynamic Treasure Group (DTG) to appeal the High Court's decision, which ruled the sale of shares to DTG as invalid. This ruling...

Grit Real Estate Announces Important AGM Details for Shareholders

Grit Real Estate Income Group's Upcoming AGM Grit Real Estate Income Group Limited, a pan-African leader in real estate, has made a significant announcement regarding its forthcoming Annual General Meeting (AGM). This event is set to take place on a Friday, specifically at 14h30 Mauritian time. Although the exact location is specified, the company invites all eligible...

Petaluma Enriches Pet Nutrition with Dr. Sarah Dodd

Petaluma Welcomes Dr. Sarah Dodd as Advisor and Formulator Petaluma, a forward-thinking sustainable pet nutrition company, is excited to announce the addition of Dr. Sarah Dodd as an Advisor and Formulator. Dr. Dodd is a renowned figure in the field of plant-based pet nutrition, bringing with her a wealth of experience to transform pet food for a sustainable and humane...